On 05 August 2021, Novo Nordisk A/S will announce the first six months of 2021 results before the opening of the NASDAQ Copenhagen stock exchange.

A conference call will follow the announcement at: 

13.00-14.00 (CEST)

12.00-13.00 (BST)

07.00-08.00 (EDT)

 

To access the conference call, please call the following numbers:

Denmark:

UK and international:

USA:

+45 3544 5577 (conference code 73726647#)

+44 333 300 0804 (conference code 73726647#)

+1 631 913 1422 (conference code 73726647#)

 

A live webcast will be available via the following link: https://edge.media-server.com/mmc/p/3yciq6tx

Company announcement

Investor presentation

Financial workbook

Conference call webcast (05 May 2021, 13:00 CET)

Conference call audio link (05 May 2021, 13:00 CET)

London webcast (06 May 2021, 13:00 CET)

London earnings presentation audio link (06 May 2021, 13:00 CET)

1 July - 5 August  2021 Silent period   
5 August 2021 Q2 2021 financial results release 
18 August 2021 Interim dividend payment for B  shares
25 August 2021 Interim dividend payment for ADRs
1 October - 3 November 2021 Silent period   
3 November 2021 Q3 2021 financial results release
1 January - 2 February 2022 Silent period
2 February 2022 Q4 2021 financial results release

28 June: R&D investor call

Presentation (Webcast)

Presentation (pdf)

 

07 June: Approval of Wegovy™ in the US

Presentation (Webcast)

Presentation (pdf)

 

21 May: International Operations call

Presentation (Webcast)

Presentation (pdf)

16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update

 

30 November: ESG conference call

9 October: Novo Nordisk raises sales and operating profit outlook for 2020

19 June: R&D investor presentation

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2020

Annual Report 2020

Download Annual Report